Defining the impact of severity of illness on time above the MIC threshold for cefepime in Gram-negative bacteraemia: a ‘Goldilocks’ window

This publication has 20 references indexed in Scilit:

• Is there a role for continuous infusion of β-lactam antibiotics in severe sepsis?
  Journal of Thoracic Disease, 2016
• A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis
  American Journal of Respiratory and Critical Care Medicine, 2015
• Evaluation of clinical outcomes in patients with Gram-negative bloodstream infections according to cefepime MIC
  Diagnostic Microbiology and Infectious Disease, 2015
• DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
  Clinical Infectious Diseases, 2014
• Continuous Infusion of Beta-Lactam Antibiotics in Severe Sepsis: A Multicenter Double-Blind, Randomized Controlled Trial
  Clinical Infectious Diseases, 2012
• Continuous infusion of antibiotics in the critically ill: The new holy grail for beta-lactams and vancomycin?
  Annals of Intensive Care, 2012
• Appraising Contemporary Strategies to Combat Multidrug Resistant Gram-Negative Bacterial Infections–Proceedings and Data From the Gram-Negative Resistance Summit
  Clinical Infectious Diseases, 2011
• A systematic review on clinical benefits of continuous administration of β-lactam antibiotics*
  Critical Care Medicine, 2009
• Failure of Current Cefepime Breakpoints To Predict Clinical Outcomes of Bacteremia Caused by Gram-Negative Organisms
  Antimicrobial Agents and Chemotherapy, 2007
• Continuous versus intermittent intravenous administration of antibiotics: a meta-analysis of randomised controlled trials
  The Lancet Infectious Diseases, 2005